How Much Can Merck's Share Price Grow If Keytruda Gets 10% Share Of Oncology Drug Market? [Forbes]
Merck & Company, Inc. (new) (MRK)
Last merck & company, inc. (new) earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.merck.com/home/default.aspx
Company Research
Source: Forbes
How Much Can Merck's Share Price Grow If Keytruda Gets 10% Share Of Oncology Drug Market? This May 1, 2018 file photo shows Merck corporate headquarters in Kenilworth, N.J. (AP Photo/Seth Wenig, File) Merck’s $16 billion What’s The Upside For Merck If Keytruda Garners An Additional 5% Share of The Oncology Drug Market By 2026? Data How Big Is The Global Oncology Drug Market? Trefis The global oncology drug market was valued at around $77 billion in 2018, and it is estimated to grow at a CAGR of 12.3% How Much Can Keytruda Sales Grow? Keytruda is the market leader in the immuno-oncology space, and it now has 15 approvals 51% reduction Given its benefits, expansion of the overall market, and if the drug is able to secure further approvals for other indications, it could garner an incremental 5% share of the global oncology drug market. Note that Keytruda is currently being tested under 9 programs in its phase three trials, including gastric, liver, and breast cancer indications. Any fr
Show less
Read more
Impact Snapshot
Event Time:
MRK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRK alerts
High impacting Merck & Company, Inc. (new) news events
Weekly update
A roundup of the hottest topics
MRK
News
- Immutep reports promising efti/Keytruda data for head and neck cancer [Seeking Alpha]Seeking Alpha
- Why Australian Cancer Biotech Firm Immutep Stock Is Soaring On Wednesday? [Yahoo! Finance]Yahoo! Finance
- Oncology Market Expected to Grow at 9.6% CAGR, Reaching USD 533.2 Bn by 2032 | DMR [Yahoo! Finance]Yahoo! Finance
- Vaccines Market Worth $94.9 billion | MarketsandMarkets™ [Yahoo! Finance]Yahoo! Finance
- BioInvent to Present Clinical Data from its Two Leading Assets at ASCO 2024 [Yahoo! Finance]Yahoo! Finance
MRK
Earnings
- 2/1/24 - Beat
MRK
Sec Filings
- 4/11/24 - Form ARS
- 4/11/24 - Form DEFA14A
- 4/11/24 - Form DEF
- MRK's page on the SEC website